Conference program

We will update and add the program as soon as it is defined:

15:30 onwards	Conference Registration / Check-In
16:00 - 17:00	Welcome Coffee & Networking
17:15 - 18:45	Anil Amin Chief Business Development Officer at Viatris David Veitch CEO at Basilea Pharmaceutica
18:45 - 19:15	Ice-breaker Swiss HLG Board Members
19:15 - 21:15	Kick-off dinner
21:15 - onwards	Networking with peers

07:00	Voluntary pre-conference morning run (meet at reception)
08:30 – 09:00	Swiss HLG General Assembly – members by invitation
09:00 - 09:10	Welcome & housekeeping Intro: External drivers of portfolio strategy
09:10 - 12:20	Melanie Senior Biopharma writer for Nature Biotechnology, Evaluate Pharma, IN VIVO Sarah Thomae Head Legal Patient Safety & Global Drug Development Transactions at Novartis
12:20 - 13:45	Lunch
13:45 - 17:00	Intro: Managing a sustainable portfolio through deal-making Speakers Jean-Marc Séquier Global BD & L, Head of Divestment, Out-Licensing and Alliance Management at Novartis Philippe Beaupere Chief Corporate Development Officer at Substipharm Kelvin Stott Founder & CEO at Amporin Pharmaceuticals Karen Wagner General Partner at Ysios Capital Frédéric Levy CSO, Head of External & Internal Innovation at Debiopharm
18:00	Swiss HLG networking dinner
22:15 - onwards	Networking with peers

07:00	Voluntary pre-conference morning run (meet at reception)
09:00 - 09:05	Welcome & Housekeeping Intro: Navigating the Unexpected: Adapting Your Portfolio Strategy
09:05 - 12:00	Peter Louwagie Senior Vice President of Corporate Development/M&A & BD&L at Genmab Marianne Spaene Chief Business Officer at Siegfried Holding AG
12:00 - 12:15	Closing remarks
12:15 - 13:30	Farewell Lunch & Networking